And double congratulations to Christin Burd who recently received two extramural grants:

(1) From the Melanoma Research Alliance – a Young Investigator Award entitled "Stromal p16NK4a as a Prognostic Indicator and Therapeutic Target"

(2) from the American Federation on Aging – a New Investigator Grant entitled "Beyond Cellular Senescence: Defining the Meaning of p16INK4a in vivo".